You are currently viewing a new version of our website. To view the old version click .

The Increasingly Fascinating World of Interleukins

This topical collection belongs to the section “Cellular Immunology“.

Topical Collection Information

Dear Colleagues,

The number of interleukin types has increased over the years, finally reaching over 40. Many interleukins play a pro-inflammatory role, but some have anti-inflammatory properties. In addition, many interleukins are produced by immune system cells, but some are also produced by non-immune-system cells. It is also interesting to note that several interleukin subfamilies share intracellular signaling. The complexity and sophistication of this system has fascinated many basic and clinical researchers. There are successful examples of bridging basic research to clinical practice; antibody drugs against interleukins and their receptors are used for treatment. In particular, expectations are now rising for the fulfilment of unmet medical needs. Regulating interleukins to control disease was a great achievement, but it is only one success story. It is now becoming clear that interleukins are involved in biological responses before the onset of disease, and that they are involved not only in intercellular networks but also in interorgan networks.

In this Topical Collection of Cells, we seek contributions either in the form of original research articles, reviews, or shorter perspective articles on all aspects related to the subject of “The Increasingly Fascinating World of Interleukins”. We would like to see the fascinating world of interleukins explained by leading experts in their respective fields of research. Papers that demonstrate mechanisms at the cellular or molecular level, in vitro or in vivo, and functional insights in basic or clinical research are welcome.

Dr. Yasu-Taka Azuma
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Interleukin
  • Immune system
  • Signal transduction
  • Target cell
  • Target receptor
  • Temporal regulation of production
  • Therapeutic applications
  • Cellular responses

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409